TITLE

The effect of urologist experience on choosing active surveillance for prostate cancer

AUTHOR(S)
Chu, William; Kim, Brian; Slezak, Jeff; Harrison, Teresa; Gelfond, Joy; Jacobsen, Steven; Chien, Gary
PUB. DATE
November 2015
SOURCE
World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1701
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To evaluate the impact of the urologist's experience in selecting active surveillance (AS) versus immediate treatment (IT) for low-risk prostate cancer. Methods: Men with low-risk prostate cancer were enrolled from March 2011 to August 2013 at 13 medical centers in Kaiser Permanente Southern California. The AS cohort was defined as men who had cT1-T2a stage prostate cancer, prostate-specific antigen <10 ng/ml, a biopsy revealing Gleason grade ≤6, fewer than three biopsy cores positive, ≤50 % cancer in any core, and not undergone immediate therapy (surgery, radiation, other) within 6 months following diagnosis. The urologist's experience ( age, number of years in practice, number of robotic surgeries performed, and fellowship experience in oncology and/or robotics) was then compared between AS and IT cohorts. Results: A total of 4754 men were diagnosed with prostate cancer, and 713 men satisfied with inclusion criteria; 433 (60.7 %) and 280 (39.3 %) chose AS and IT, respectively. A total of 87 urologists were included. Univariate and multivariate adjusted analyses revealed no differences in urologist's age or years in practice. Patients who saw urologists who had performed ≥50 robotic surgeries were less likely to choose AS (OR 0.40, 95 % CI 0.25-0.66). Patients who saw urologists with a fellowship in oncology and/or robotics were more than twice as likely to choose AS (OR 2.27, 95 % CI 1.38-3.75). Conclusion: These data suggest that the decision to pursue AS may be influenced by the urologist's experience.
ACCESSION #
110527849

 

Related Articles

  • Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. Tewes, Susanne; Hueper, Katja; Hartung, Dagmar; Imkamp, Florian; Herrmann, Thomas; Weidemann, Juergen; Renckly, Stefan; Kuczyk, Markus; Wacker, Frank; Peters, Inga // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1707 

    Purpose: To evaluate a novel system for MRI/TRUS fusion-guided biopsy for detection of prostate cancer (PCa) in patients with previous negative prostate biopsy and determine diagnostic accuracy when using the Prostate Imaging Reporting and Data System (PI-RADS) for multiparametric magnetic...

  • An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? Feletto, E.; Bang, A.; Cole-Clark, D.; Chalasani, V.; Rasiah, K.; Smith, D. // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1677 

    Purpose: To compare prostate cancer incidence and mortality rates in Australia, USA, Canada and England and quantify the gap between observed prostate cancer deaths in Australia and expected deaths, using US mortality rates. Methods: Analysis of age-standardised prostate cancer incidence and...

  • Does transperitoneal minimally invasive radical prostatectomy increase the amount of small bowel receiving salvage radiation? Luz, Murilo A.; Pra, Alan Dal; Vincent Tu, Hin-Yu; Duclos, Marie; Cury, Fabio L. B.; Bachir, Bassel G.; Aprikian, Armen G.; Tanguay, Simon; Kassouf, Wassim // Canadian Urological Association Journal;Nov/Dec2013, Vol. 7 Issue 11-12, p444 

    Introduction: Transperitoneal minimally invasive radical prostatectomy (MIRP) has become first choice for several urologists and patients dealing with localized prostate cancer. We evaluate the effect of postoperative radiation on the small bowel in patients who underwent extraperitoneal open...

  • Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. Langsenlehner, Tanja; Thurner, Eva-Maria; Krenn-Pilko, Sabine; Langsenlehner, Uwe; Stojakovic, Tatjana; Gerger, Armin; Pichler, Martin // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1661 

    Purpose: Recent studies have expanded the concept that the systemic inflammatory response has an important role in the progression of several solid tumors. The neutrophil-to-lymphocyte ratio (NLR), an easily determinable marker of systemic inflammation, has been associated with clinical outcome...

  • Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Thörmer, Gregor; Otto, Josephin; Reiss-Zimmermann, Martin; Seiwerts, Matthias; Moche, Michael; Garnov, Nikita; Franz, Toni; Do, Minh; Stolzenburg, Jens-Uwe; Horn, Lars-Christian; Kahn, Thomas; Busse, Harald // European Radiology;Aug2012, Vol. 22 Issue 8, p1820 

    Objectives: To evaluate the influence of the choice of b values on the diagnostic value of the apparent diffusion coefficient (ADC) for detection and grading of prostate cancer (PCa). Methods: Forty-one patients with biopsy-proven PCa underwent endorectal 3-T MRI before prostatectomy. Different...

  • Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey. Ariane, Mehdi; Ploussard, Guillaume; Rebillard, Xavier; Malavaud, Bernard; Rischmann, Pascal; Hennequin, Christophe; Mongiat-Artus, Pierre // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1741 

    Introduction: Through a cross-sectional survey, we tried to assess whether practices of urologists and radiation oncologists are uniform when faced with similar clinical situations. Materials and Methods: A self-administered questionnaire was mailed to all French urologists and radiation...

  • Five-Year RARP Outcomes Are 'Highly Satisfactory,' Researchers Conclude.  // Renal & Urology News;May2011, Vol. 10 Issue 5, p15 

    The article focuses on the results of the five-year oncologic outcomes of robot-assisted radical prostatectomy (RARP) for patients with organ-confined localized prostate cancer (PCa) as studied by the research team led by doctor Nazareno Suardi.

  • Radiotherapy after prostatectomy increased PFS in pT3 prostate cancer. Adams, Stacey L.; Haigh, Christen; Harris, Jason; Lewis, Jay; Southall, Jen; Volansky, Rob // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p38 

    The article discusses research on the effect of radiotherapy after prostatectomy on progression-free survival (PFS) in pT3 prostate cancer patients, which references a study by J. Wiegel published in a 2009 issue of the "Journal of Clinical Oncology."

  • Treatment modalities for Māori and New Zealand European men with localised prostate cancer. Obertová, Zuzana; Lawrenson, Ross; Scott, Nina; Holmes, Michael; Brown, Charis; Lao, Chunhuan; Tyrie, Leanne; Gilling, Peter // International Journal of Clinical Oncology;Aug2015, Vol. 20 Issue 4, p814 

    Objectives: To examine diagnostic and treatment pathways for Māori (the indigenous people of New Zealand [NZ]) and NZ European men with prostate cancer in order to identify causes of higher mortality rates for Māori men. Methods: All Māori men (150) diagnosed with prostate cancer in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics